Why your gut might hold the key to calmer allergy season

This post contains affiliate links. If you buy through them I may earn a small commission at no extra cost to you, and you’ll receive 20% off with my link. I only ever recommend products I genuinely rate.

If you find that June arrives and so does a familiar low-grade misery — the itchy eyes, the sneezing, the skin that suddenly wants to flare, the digestion that feels inexplicably more reactive — you are far from alone. Seasonal allergies affect roughly one in four adults in the UK, and the conventional approach tends to be the same: antihistamines, decongestants, perhaps a nasal spray, and the resigned acceptance that this is just something you manage rather than address.

But what if the real leverage point wasn’t in your medicine cabinet at all?

A growing body of research is pointing somewhere unexpected: the gut. More specifically, it is pointing to a short-chain fatty acid called butyrate — and its surprisingly direct relationship with the immune cells responsible for releasing histamine in the first place.

What mast cells actually do, and why they matter for allergy sufferers

To understand the butyrate connection, it helps to start with mast cells. These are specialised immune cells found in the tissues where your body interfaces with the outside world — your skin, your respiratory lining, your gut wall. Their job is to act as rapid-response sentinels: when they detect a threat (an allergen, a pathogen, a toxin), they degranulate, releasing a cascade of inflammatory mediators that include histamine, tryptase, and interleukin-6.

In an acute infection, this response is exactly what you want. The problem arises when mast cells become chronically overactivated — firing repeatedly at things that aren’t genuine threats, whether pollen, certain foods, or environmental triggers. This is the underlying mechanism behind hay fever, skin reactivity, histamine intolerance, and a significant proportion of what people describe as “sensitive digestion.”

Most antihistamines work downstream of this process — they block the histamine receptor after the histamine has already been released. They manage the symptom, but don’t address the reason mast cells are firing so readily in the first place.

Butyrate: a short-chain fatty acid with a surprisingly direct mechanism

Butyrate is a short-chain fatty acid (SCFA) produced in the colon when beneficial gut bacteria ferment dietary fibre. It is the primary fuel source for colonocytes (the cells lining your colon), and it plays a central role in maintaining gut barrier integrity and modulating immune responses throughout the body.

Here is where the research becomes genuinely interesting.

A 2020 study published in Allergy (Folkerts et al., Utrecht University and Erasmus MC Rotterdam) investigated the effects of SCFAs — including butyrate — on human mast cell activation. The researchers found that butyrate inhibited IgE-mediated and non-IgE-mediated mast cell degranulation in both human and mouse cells, in a concentration-dependent manner. Crucially, this effect was not achieved through SCFA receptors (GPR41 or GPR43), but through epigenetic regulation — specifically, the inhibition of histone deacetylases (HDACs). Butyrate effectively downregulated the expression of three tyrosine kinases (BTK, SYK, and LAT) that are critical transducers of the FcεRI signalling cascade responsible for triggering mast cell degranulation. In plain terms: it appeared to turn down the genetic volume on the very switch that tells mast cells to fire. Read the full study.

A separate study published in Nutrients corroborated this picture, finding that sodium butyrate strengthened intestinal barrier integrity and inhibited mast cell activation and the release of inflammatory mediators — including histamine and TNF-α — in an animal model. Read the full study.

This is a meaningful distinction from the standard allergy narrative, and one worth sitting with: the problem may not simply be that histamine is being released — it may be that mast cells are insufficiently regulated, and that the gut environment is a primary determinant of how well that regulation functions.

The butyrate gap in modern diets

Most people in the UK are not producing enough butyrate. The reason is straightforward: butyrate is produced by bacterial fermentation of fermentable dietary fibre — the kinds found in foods like chicory root, Jerusalem artichoke, garlic, leeks, oats, and legumes. Modern diets, stripped of these fibres and often disrupted by antibiotic use, chronic stress, and ultra-processed food, tend to support far lower populations of the butyrate-producing bacteria (primarily Firmicutes species, including Faecalibacterium prausnitzii and Roseburia intestinalis).

The result is a measurable shortfall in colonic butyrate — which in turn may contribute to compromised gut barrier function, dysregulated immune responses, and the kind of chronically reactive mast cell activity that underpins persistent allergy symptoms.

This is one reason that simply adding fibre or probiotics doesn’t always resolve the picture quickly: if the butyrate-producing bacterial populations have been depleted, rebuilding them takes time. A more direct route is to supplement with butyrate itself — but here, the form matters considerably.

Why the form of butyrate you take matters

Standard butyrate supplements — typically sodium butyrate or calcium/magnesium butyrate — are absorbed rapidly in the upper gastrointestinal tract and often fail to reach the colon in meaningful concentrations, which is precisely where the immune regulation occurs. They also have a notably unpleasant odour that makes them impractical for daily use.

Tributyrin is a different matter. Tributyrin is a naturally occurring fat — a triglyceride of butyric acid — that is digested more slowly, allowing it to be released progressively along the gastrointestinal tract, including the colon. A 2025 pharmacokinetic study confirmed that tributyrin supplementation meaningfully raises butyrate levels and supports healthy gut microbial composition — delivering butyrate where it is actually needed. Read the full study.

Where Biome Protect fits

Adapt Naturals Biome Protect contains CoreBiome® Tributyrin at 300 mg per serving — one of the few supplements on the market to use the clinically substantiated tributyrin form of butyrate. It sits within a broader 4-in-1 formula that combines:

• Bacillus coagulans (2 billion CFU) — a spore-forming probiotic that survives gastric acid and supports gut resilience
• FortiPhage (15 mg) — a next-generation bacteriophage prebiotic that supports the growth of beneficial bacteria
• CoreBiome® Tributyrin (300 mg) — the bioavailable postbiotic that delivers butyrate directly to the colon
• Polyphenol blend (200 mg) — pomegranate, grape seed, cranberry, and blueberry extracts for antioxidant support

The rationale for combining these four components reflects something important about gut health: probiotics, prebiotics, postbiotics, and polyphenols act synergistically on the gut ecosystem. You are not just supplementing butyrate in isolation — you are supporting the environment in which butyrate-producing bacteria can thrive longer-term.

Practical takeaways

Supporting a healthier mast cell and histamine response through the gut is not a quick fix, and it is worth being honest about that. The research suggests a real mechanism, but the timeline for gut remodelling is measured in weeks to months, not days.

Start with fibre diversity, not just quantity. Variety of fermentable fibres matters more than volume. Rotating sources — leeks, garlic, asparagus, oats, lentils, chicory — feeds a broader range of butyrate-producing species than any single fibre source alone.

Consistency is the lever. The Folkerts et al. study demonstrated concentration-dependent effects of butyrate on mast cell activation — meaning the benefit scales with sustained exposure, not a single dose. Daily supplementation alongside a fibre-rich diet is more likely to produce meaningful results than intermittent use.

Consider the broader picture. Chronic stress, poor sleep, and antibiotic use all deplete butyrate-producing bacteria. Addressing these alongside supplementation gives the gut ecology the conditions it needs to stabilise.

Speak to a professional first if relevant. For people managing diagnosed mast cell activation syndrome, mastocytosis, or severe histamine intolerance, any changes to supplementation should be discussed with a GP or registered specialist.

The gut-allergy connection is one of the more compelling areas of emerging nutritional science, and I find it genuinely useful to have a mechanistic framework for why some people experience persistent reactivity even when they’ve tried the conventional routes. The butyrate research gives us a more upstream target — and one that, admittedly, most allergy conversations haven’t reached yet.

---

This article is for educational purposes and isn’t medical advice. Supplements aren’t a substitute for a varied diet or medical care. If you’re pregnant, breastfeeding, taking medication, or managing a health condition, speak to your GP or a registered professional before starting anything new.